{"title": "TIV High Dose Influenza Vaccine", "author": "Staff", "url": "https://www.precisionvaccinations.com/vaccines/tiv-high-dose-influenza-vaccine", "hostname": "precisionvaccinations.com", "description": "UK marketing authorization was granted for Sanofi Pasteur's Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2", "sitename": "Precision Vaccinations", "date": "2020-02-19", "cleaned_text": "High Dose Influenza Vaccine contains the following inactive viruses for the 2019-2020 season: - TIV High Dose Indication TIV High Dose is indicated for active immunization of people 65 years of age and older against influenza disease in the UK. TIV High Dose Vaccine Dosage Immune defenses naturally decline with advancing age, which can cause immune responses to vaccines to diminish. This natural decline also means that older adults are particularly vulnerable to influenza infection and its complications. TIV High Dose has therefore been designed specifically to improve protection against influenza compared to standard dose TIV for this senior population. "}